TipRanks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
US Market
LXRX
Lexicon Pharmaceuticals
RESEARCH TOOLSreports
Want to see LXRX full AI Analyst Report?

Lexicon Pharmaceuticals (LXRX) Ratios

1,822 Followers

Lexicon Pharmaceuticals Ratios

LXRX's free cash flow for Q2 2026 was $0.94. For the 2026 fiscal year, LXRX's free cash flow was decreased by $ and operating cash flow was $-42.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 13.37 4.88 5.44 5.60 6.08
Quick Ratio
 13.29 4.87 5.44 5.58 6.08
Cash Ratio
 2.78 1.64 1.47 0.71 2.00
Solvency Ratio
 -0.80 -0.64 -1.31 -1.30 -1.32
Operating Cash Flow Ratio
 -5.42 -3.25 -3.95 -5.13 -3.83
Short-Term Operating Cash Flow Coverage
 0.00 -10.88 0.00 0.00 0.00
Net Current Asset Value
$ 121.04M$ 24.45M$ 93.72M$ 40.23M$ 63.69M
Leverage Ratios
Debt-to-Assets Ratio
 0.24 0.34 0.36 0.46 0.28
Debt-to-Equity Ratio
 0.34 0.58 0.74 1.14 0.47
Debt-to-Capital Ratio
 0.25 0.37 0.43 0.53 0.32
Long-Term Debt-to-Capital Ratio
 0.23 0.31 0.41 0.52 0.29
Financial Leverage Ratio
 1.43 1.72 2.04 2.46 1.66
Debt Service Coverage Ratio
 -6.23 -2.84 -11.83 -12.96 -35.98
Interest Coverage Ratio
 -6.50 -5.87 -12.65 -13.11 -36.24
Debt to Market Cap
 0.06 0.13 0.42 0.29 0.15
Interest Debt Per Share
 0.15 0.19 0.39 0.54 0.35
Net Debt to EBITDA
 -0.35 -0.67 -0.23 -0.49 -0.09
Profitability Margins
Gross Profit Margin
98.85%99.45%98.02%-4798.01%-37681.29%
EBIT Margin
-127.16%-84.34%-594.65%-14145.35%-72273.38%
EBITDA Margin
-126.00%-83.09%-592.93%-14099.34%-71966.19%
Operating Profit Margin
-131.43%-98.21%-634.20%-14264.95%-72489.21%
Pretax Profit Margin
-147.38%-101.08%-644.78%-14710.88%-73341.01%
Net Profit Margin
-147.38%-101.08%-644.78%-14710.88%-73341.01%
Continuous Operations Profit Margin
-147.38%-101.08%-644.78%-14710.88%-73341.01%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
112.14%102.92%101.67%103.13%101.18%
Return on Assets (ROA)
-24.44%-27.21%-67.15%-77.20%-52.47%
Return on Equity (ROE)
-40.40%-46.81%-137.31%-190.23%-87.04%
Return on Capital Employed (ROCE)
-23.16%-29.80%-77.86%-86.79%-58.88%
Return on Invested Capital (ROIC)
-23.00%-28.71%-77.50%-86.23%-58.44%
Return on Tangible Assets
-29.74%-35.84%-78.94%-95.80%-68.07%
Earnings Yield
-7.67%-12.06%-84.79%-52.35%-32.20%
Efficiency Ratios
Receivables Turnover
 25.24 20.89 8.95 1.19 4.96
Payables Turnover
 0.20 0.09 0.04 4.10 5.05
Inventory Turnover
 0.40 0.98 2.67 154.78 0.00
Fixed Asset Turnover
 4.84 5.42 4.25 0.16 0.02
Asset Turnover
 0.17 0.27 0.10 <0.01 <0.01
Working Capital Turnover Ratio
 0.23 0.35 0.18 <0.01 <0.01
Cash Conversion Cycle
 -865.07 -3.72K -8.59K 219.49 1.28
Days of Sales Outstanding
 14.46 17.47 40.79 306.19 73.53
Days of Inventory Outstanding
 917.10 374.32 136.88 2.36 0.00
Days of Payables Outstanding
 1.80K 4.11K 8.77K 89.06 72.25
Operating Cycle
 931.56 391.80 177.66 308.55 73.53
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.18 -0.19 -0.56 -0.73 -0.54
Free Cash Flow Per Share
 -0.18 -0.19 -0.56 -0.73 -0.54
CapEx Per Share
 0.00 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -173.40 -344.46 -67.01
Capital Expenditure Coverage Ratio
 0.00 0.00 -173.40 -344.46 -67.01
Operating Cash Flow Coverage Ratio
 -1.34 -1.09 -1.65 -1.53 -1.61
Operating Cash Flow to Sales Ratio
 -1.92 -1.36 -5.75 -134.47 -639.22
Free Cash Flow Yield
-9.86%-16.25%-76.08%-47.99%-28.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -12.47 -8.21 -1.17 -1.91 -3.11
Price-to-Sales (P/S) Ratio
 20.08 8.38 7.60 281.00 2.28K
Price-to-Book (P/B) Ratio
 4.70 3.88 1.62 3.63 2.70
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.45 -6.15 -1.31 -2.08 -3.51
Price-to-Operating Cash Flow Ratio
 -10.29 -6.15 -1.32 -2.09 -3.56
Price-to-Earnings Growth (PEG) Ratio
 0.10 0.11 0.06 -0.07 -1.89
Price-to-Fair Value
 4.70 3.88 1.62 3.63 2.70
Enterprise Value Multiple
 -16.29 -10.76 -1.51 -2.49 -3.25
Enterprise Value
 826.79M 445.42M 278.08M 421.93M 325.50M
EV to EBITDA
 -15.82 -10.76 -1.51 -2.49 -3.25
EV to Sales
 19.94 8.94 8.95 350.44 2.34K
EV to Free Cash Flow
 -10.37 -6.56 -1.55 -2.60 -3.61
EV to Operating Cash Flow
 -10.37 -6.56 -1.56 -2.61 -3.66
Tangible Book Value Per Share
 0.30 0.17 0.32 0.22 0.44
Shareholders’ Equity Per Share
 0.40 0.30 0.46 0.42 0.71
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.09 0.14 0.10 <0.01 <0.01
Net Income Per Share
 -0.14 -0.14 -0.63 -0.80 -0.62
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.16 1.20 1.08 1.04 1.01
Research & Development to Revenue
 1.45 1.23 2.72 48.91 379.97
SG&A to Revenue
 0.85 0.75 4.24 0.00 0.00
Stock-Based Compensation to Revenue
 0.38 0.25 0.43 11.91 82.88
Income Quality
 1.28 1.35 0.89 0.91 0.87
Currency in USD